logo

Jerry Mendell, MD

Jerry Mendell, MD

Neurology Columbus, OH

Professor of Pediatrics and Neurology, Ohio State University

Office Address

Office Map
  • 700 Children's Dr
    WA3011
    Columbus, OH 43205
    Phone: (614) 722-5615
    Fax: (614) 722-3273

Dr. Mendell's Clinical Specialties & Interests

  • Neurology: Neuromuscular Medicine

Dr. Mendell's Education & Medical Training

  • New York Presbyterian Hospital, Columbia CampusNew York Presbyterian Hospital, Columbia CampusResidency, Anatomic and Clinical Pathology
  • New York Presbyterian Hospital, Columbia CampusNew York Presbyterian Hospital, Columbia CampusResidency, Neurology
  • New York Presbyterian Hospital, Columbia CampusNew York Presbyterian Hospital, Columbia CampusResidency, General Surgery
  • U of TX SW Med Ctr at Dallas, Med SchUniversity of Texas Southwestern Medical SchoolMedical School

Dr. Mendell's Certifications & Licensure

  • OH State Medical LicenseOH State Medical LicenseActive through 2014
  • American Board of Psychiatry and NeurologyAmerican Board of Psychiatry and NeurologyNeurology, 1972

Dr. Mendell's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Vascular Delivery Of Alpha-Sarcoglycan For Lgmd2d
    Vascular Delivery Of Alpha-Sarcoglycan For Lgmd2dNational Institute Of Arthritis And Musculoskeletal And Skin Diseases
    2011 - 2011
  • Overcoming Immune Barriers To Gene Correction For Duchenne Muscular Dystrophy
    Overcoming Immune Barriers To Gene Correction For Duchenne Muscular DystrophyEunice Kennedy Shriver National Institute Of Child Health &Human Development
    2010 - 2011
  • The Implications Of Dystrophin-Specific T Cells For DMD Gene Correction
    The Implications Of Dystrophin-Specific T Cells For DMD Gene CorrectionEunice Kennedy Shriver National Institute Of Child Health &Human Development
    2010 - 2011
  • Administrative Core
    Administrative CoreEunice Kennedy Shriver National Institute Of Child Health &Human Development
    2010 - 2011
  • Clinical Trial: Six-Month (26 Weeks) Clinical Trial Of Gentamicin In Duchenne MD
    Clinical Trial: Six-Month (26 Weeks) Clinical Trial Of Gentamicin In Duchenne MDNational Center For Research Resources
    2008 - 2008
  • Diverse Strategies To Correct The Dystrophin Gene Using Vascular Delivery (U54)
    Diverse Strategies To Correct The Dystrophin Gene Using Vascular Delivery (U54)National Institute Of Neurological Disorders And Stroke
    2007 - 2010
  • Implementing Newborn Screening For Duchenne Muscular Dystrophy In The Community
    Implementing Newborn Screening For Duchenne Muscular Dystrophy In The CommunityCenters For Disease Control And Prevention
    2007 - 2009
  • Dystrophin Restoration
    Dystrophin RestorationNational Institute Of Neurological Disorders And Stroke
    2007 - 2010
  • Administrative Core
    Administrative CoreNational Institute Of Neurological Disorders And Stroke
    2007 - 2007
  • Study Of SR 57746a In Patients With Amyotrophic Lateral Sclerosis
    Study Of SR 57746a In Patients With Amyotrophic Lateral SclerosisNational Center For Research Resources
    2007 - 2007
  • Study Of MYO-029
    Study Of MYO-029National Center For Research Resources
    2007 - 2007
  • Six-Month (26 Weeks) Clinical Trial Of Gentamicin In Duchenne MD
    Six-Month (26 Weeks) Clinical Trial Of Gentamicin In Duchenne MDNational Center For Research Resources
    2006 - 2007
  • Gentamicin Trial In Duchenne And Limb Girdle Dystrophies
    Gentamicin Trial In Duchenne And Limb Girdle DystrophiesNational Institute Of Neurological Disorders And Stroke
    2004 - 2004
  • Newborn Screening For Duchenne Muscular Dystrophy
    Newborn Screening For Duchenne Muscular DystrophyCenters For Disease Control And Prevention
    2004 - 2007
  • Developing Clinical Outcomes For Gene Transfer
    Developing Clinical Outcomes For Gene TransferNational Institute Of Arthritis And Musculoskeletal And Skin Diseases
    2003 - 2008
  • Gentamicin Trial In Duchenne And Limb Girdle Dystrophies
    Gentamicin Trial In Duchenne And Limb Girdle DystrophiesNational Institute Of Neurological Disorders And Stroke
    2002 - 2003
  • Safety, Efficacy And Tolerability Of Beta Interferon1a In Inclusion Body Myositis
    Safety, Efficacy And Tolerability Of Beta Interferon1a In Inclusion Body MyositisNational Center For Research Resources
    2000 - 2000
  • Treatment Of Patients With Amyotrophic Lateral Sclerosis Using A Ketogenic Diet
    Treatment Of Patients With Amyotrophic Lateral Sclerosis Using A Ketogenic DietNational Center For Research Resources
    2000 - 2000
  • Efficacy, Safety, Tolerability Of Sr57746a In ALS Patients
    Efficacy, Safety, Tolerability Of Sr57746a In ALS PatientsNational Center For Research Resources
    1999 - 2001
  • Great Lakes ALS Study Group
    Great Lakes ALS Study GroupNational Center For Research Resources
    1999 - 2001
  • LGMD Study Group
    LGMD Study GroupNational Center For Research Resources
    1999 - 2001
  • Efficacy Of Sr57746a In Patients With Amyotrophic Lateral Sclerosis
    Efficacy Of Sr57746a In Patients With Amyotrophic Lateral SclerosisNational Center For Research Resources
    1998 - 2001
  • Clinical Trial Of Oxandrin In Treatment Of Duchennes Muscular Dystrophy
    Clinical Trial Of Oxandrin In Treatment Of Duchennes Muscular DystrophyNational Center For Research Resources
    1998 - 2001
  • Multicenter Trial In Periodic Paralysis And Sodium Channel Disorder
    Multicenter Trial In Periodic Paralysis And Sodium Channel DisorderNational Center For Research Resources
    1997 - 1997
  • Intravenous Immunoglobulin In Cipd
    Intravenous Immunoglobulin In CipdNational Center For Research Resources
    1996 - 2001
  • Androgen Hormone Deficiency And Replacement In Motor Neuron Disease
    Androgen Hormone Deficiency And Replacement In Motor Neuron DiseaseNational Center For Research Resources
    1996 - 1997
  • Myoblast Transfer Studies In Duchenne Muscular Dystrophy
    Myoblast Transfer Studies In Duchenne Muscular DystrophyNational Center For Research Resources
    1996 - 1996
  • Multicenter Trial In Periodic Paralysis &Associated Sodium Channel Disorder
    Multicenter Trial In Periodic Paralysis &Associated Sodium Channel DisorderNational Center For Research Resources
    1996 - 1996

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • Anthem Blue Access PPO
  • Anthem Blue Preferred HMO
  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • BCBS Texas BlueChoice
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • HealthAmerica HealthAssurance PPO
  • Humana ChoiceCare Network PPO
  • Medical Mutual of Ohio SuperMed Plus
  • Medical Mutual of Ohio SuperMed POS
  • Multiplan PHCS PPO
  • Multiplan PPO
  • UniCare PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Physicians, view Dr. Mendell's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV